Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F NEWMAN

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 1, 1988
Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)H F Newman, N M Bleehen, R Ward, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1988
The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)H F Newman, R Ward, P Workman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
A multiple dose study of the combined radiosensitizers Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)N M Bleehen, H F Newman, T S Maughan, et al.
Medical Care|November 1, 1975
Impact of integration of mental health service and comprehensive medical careW S Kogan, D J Thompson, J R Brown, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
Palliative radiotherapy for lung cancer: two versus five fractionsG J Rees, C E Devrell, V L Barley, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1989
Estimation of plasma area under the curve for etanidazole (SR 2508) in toxicity prediction and dose adjustmentP Workman, R Ward, T S Maughan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in manP Workman, H F Newman, N M Bleehen, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1990
Abnormal clinical pharmacokinetics of the developmental radiosensitizers pimonidazole (Ro 03-8799) and etanidazole (SR 2508)T S Maughan, H F Newman, N M Bleehen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1991
The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic studyN M Bleehen, T S Maughan, P Workman, et al.
American Journal of Nephrology|January 1, 1990
Hemolysis associated with hydrogen peroxide at a pediatric dialysis centerS M Gordon, L A Bland, S R Alexander, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|September 1, 1988
Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)H F Newman, N M Bleehen, R Ward, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1988
The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)H F Newman, R Ward, P Workman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
A multiple dose study of the combined radiosensitizers Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)N M Bleehen, H F Newman, T S Maughan, et al.
Medical Care|November 1, 1975
Impact of integration of mental health service and comprehensive medical careW S Kogan, D J Thompson, J R Brown, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
Palliative radiotherapy for lung cancer: two versus five fractionsG J Rees, C E Devrell, V L Barley, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1989
Estimation of plasma area under the curve for etanidazole (SR 2508) in toxicity prediction and dose adjustmentP Workman, R Ward, T S Maughan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in manP Workman, H F Newman, N M Bleehen, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1990
Abnormal clinical pharmacokinetics of the developmental radiosensitizers pimonidazole (Ro 03-8799) and etanidazole (SR 2508)T S Maughan, H F Newman, N M Bleehen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1991
The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic studyN M Bleehen, T S Maughan, P Workman, et al.
American Journal of Nephrology|January 1, 1990
Hemolysis associated with hydrogen peroxide at a pediatric dialysis centerS M Gordon, L A Bland, S R Alexander, et al.
Pageof 3